Co-Payments Cut Statin Use
TUESDAY, April 10 (HealthDay News) -- Many patients taking statins to lower their cholesterol stop taking the drugs because of co-payments and shared drug costs, a new study found.
These drugs, which have been shown to prevent heart attacks, should be fully covered by insurance, said study lead researcher Dr. Sebastian Schneeweiss, an associate professor of medicine and epidemiology at Harvard Medical School.
"There are a bunch of conditions, like high cholesterol, where patients should be totally exempted from any cost-sharing just in order for them to take the medication," Schneeweiss said. "The patient's health will be better, but it also makes economic sense for the insurance plan -- if the plan is thinking not just about the pharmacy cost but the overall costs. The cost to insurance companies to treat a heart attack is far more than the cost to prevent one."
Schneeweiss thinks that because statins are a preventive drug, they may be easy for someone to discontinue when cost becomes an issue.Read entire article...